HER2-positive Recurrent or Metastatic Malignant Solid Tumor
1 clinical trials · Condition
◉ Watch HER2-positive Recurrent or Metastatic Malignant Solid Tumor
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor (NCT03842085) | Beijing Mabworks Biotech Co., Ltd. | 2019-04-11 |
Track HER2-positive Recurrent or Metastatic Malignant Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.